Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/FDA-Approves-First-in-class-Evkeeza-evinacumab-dgnb-for-Young-Children-with-Ultra-rare-Form-of-H-43308065/?utm_source=whatsapp&utm_medium=social&utm_campaign=share